Emily B Schroeder

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. pmc An Innovative Approach to Informing Research: Gathering Perspectives on Diabetes Care Challenges From an Online Patient Community
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, United States
    Interact J Med Res 4:e13. 2015
  2. pmc Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation
    Emily B Schroeder
    Institute for Health Research and
    Clin J Am Soc Nephrol 12:87-94. 2017
  3. doi request reprint Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado University of Colorado School of Medicine, Aurora, Colorado Electronic address
    J Diabetes Complications 29:637-43. 2015
  4. pmc Gender differences in cardiovascular risk factors in incident diabetes
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado Department of Medicine, University of Colorado Denver, Aurora, Colorado Electronic address
    Womens Health Issues 24:e61-8. 2014
  5. pmc Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80237 8066, USA
    Circ Cardiovasc Qual Outcomes 5:645-53. 2012
  6. pmc Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders
    Marsha A Raebel
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80237, USA
    J Gen Intern Med 27:57-64. 2012
  7. doi request reprint Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO, USA
    Ann Pharmacother 47:1280-91. 2013
  8. doi request reprint Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO, USA University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
    Pharmacoepidemiol Drug Saf 23:699-710. 2014
  9. doi request reprint Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80231, USA
    J Comp Eff Res 3:359-69. 2014
  10. doi request reprint Importance of including early nonadherence in estimations of medication adherence
    Marsha A Raebel
    Institute for Health Research, Kaiser Permanente Colorado, Denver, USA
    Ann Pharmacother 45:1053-60. 2011

Detail Information

Publications10

  1. pmc An Innovative Approach to Informing Research: Gathering Perspectives on Diabetes Care Challenges From an Online Patient Community
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, United States
    Interact J Med Res 4:e13. 2015
    ..Despite calls for greater patient engagement, few studies have engaged a broad-based online community of patient stakeholders in the early stages of the research development process...
  2. pmc Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation
    Emily B Schroeder
    Institute for Health Research and
    Clin J Am Soc Nephrol 12:87-94. 2017
    ..Our objective was to develop and externally validate a clinically useful and pragmatic prediction model for the 5-year risk of progression to RRT in stage 3 or 4 CKD...
  3. doi request reprint Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado University of Colorado School of Medicine, Aurora, Colorado Electronic address
    J Diabetes Complications 29:637-43. 2015
    ..We used data from 11 integrated health systems in the United States to estimate CKD prevalence in adults with diabetes (2005-2011), and compare the effect of different ascertainment methods on prevalence estimates...
  4. pmc Gender differences in cardiovascular risk factors in incident diabetes
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado Department of Medicine, University of Colorado Denver, Aurora, Colorado Electronic address
    Womens Health Issues 24:e61-8. 2014
    ....
  5. pmc Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80237 8066, USA
    Circ Cardiovasc Qual Outcomes 5:645-53. 2012
    ..We assessed the incidence and duration of simultaneous control of hyperglycemia, blood pressure, and low-density lipoprotein cholesterol in patients from 2 health care systems in Colorado...
  6. pmc Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders
    Marsha A Raebel
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80237, USA
    J Gen Intern Med 27:57-64. 2012
    ....
  7. doi request reprint Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO, USA
    Ann Pharmacother 47:1280-91. 2013
    ..Among adults with incident diabetes, data are lacking about first antihyperglycemic initiation and whether medication choice aligns with recommendations...
  8. doi request reprint Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO, USA University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
    Pharmacoepidemiol Drug Saf 23:699-710. 2014
    ..We characterized the first intensification the year after oral antihyperglycemic medication initiation among incident diabetes patients...
  9. doi request reprint Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies
    Emily B Schroeder
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80231, USA
    J Comp Eff Res 3:359-69. 2014
    ..Recommendations for defining CKD require multiple longitudinal measurements. The implications of applying these definitions to EHR data are poorly understood...
  10. doi request reprint Importance of including early nonadherence in estimations of medication adherence
    Marsha A Raebel
    Institute for Health Research, Kaiser Permanente Colorado, Denver, USA
    Ann Pharmacother 45:1053-60. 2011
    ..As a result, published studies may overestimate adherence, but the extent of overestimation posed by not considering patients with primary nonadherence and early nonpersistence has not been assessed...